Previous Close | 8.36 |
Open | 8.37 |
Bid | 0.00 x 1800 |
Ask | 8.44 x 28000 |
Day's Range | 8.36 - 8.44 |
52 Week Range | 7.70 - 8.99 |
Volume | |
Avg. Volume | 5,696,366 |
Market Cap | 38.401B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 30.04 |
EPS (TTM) | 0.28 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.21 (2.53%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | 9.57 |
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.